Neurocrine Biosciences (NBIX) Debt Ratio (2018 - 2024)

Neurocrine Biosciences has reported Debt Ratio for 6 years, with the latest figure at 0.04 in Q1 2024.

• For the quarter ending Q1 2024, Debt Ratio changed N/A year-over-year to 0.04; the trailing twelve-month figure through Mar 2024 stood at 0.04 (changed N/A YoY), and the FY2023 full-year result was 0.05, down 26.85% from the prior year.
• Debt Ratio for Q1 2024 stood at 0.04, down from 0.05 in the prior quarter.
• The five-year high for Debt Ratio was 0.28 in Q3 2020, with the low at 0.04 in Q1 2024.
• Historically, Debt Ratio has averaged 0.12 across 4 years, with a median of 0.07 in 2022.
• The largest YoY upside for Debt Ratio was 24.43% in 2023 against a maximum downside of 26.85% in 2023.
• Neurocrine Biosciences' Debt Ratio stood at 0.28 in 2020, then sank by 74.72% to 0.07 in 2022, then decreased by 26.85% to 0.05 in 2023, then sank by 32.4% to 0.04 in 2024.
• The last three Debt Ratio figures came in at 0.04 (Q1 2024), 0.05 (Q4 2023), and 0.06 (Q3 2023), per Business Quant data.